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ABSTRACT The Ca2þ channel a1S subunit (CaV1.1) is the voltage sensor in skeletal muscle excitation-contraction (EC)
coupling. Upon membrane depolarization, this sensor rapidly triggers Ca2þ release from internal stores and conducts a slowly
activating Ca2þ current. However, this Ca2þ current is not essential for skeletal muscle EC coupling. Here, we identiﬁed a CaV1.1
splice variant with greatly distinct current properties. The variant of the CACNA1S gene lacking exon 29 was expressed at low
levels in differentiated human and mouse muscle, and up to 80% in myotubes. To test its biophysical properties, we deleted exon
29 in a green ﬂuorescent protein (GFP)-tagged a1S subunit and expressed it in dysgenic (a1S-null) myotubes. GFP-a1SD29 was
correctly targeted into triads and supported skeletal muscle EC coupling. However, the Ca2þ currents through GFP-a1SD29
showed a 30-mV left-shifted voltage dependence of activation and a substantially increased open probability, giving rise to an
eightfold increased current density. This robust Ca2þ inﬂux contributed substantially to the depolarization-induced Ca2þ transient
that triggers contraction. Moreover, deletion of exon 29 accelerated current kinetics independent of the auxiliary a2d-1 subunit.
Thus, characterizing the CaV1.1D29 splice variant revealed the structural bases underlying the speciﬁc gating properties of
skeletal muscle Ca2þ channels, and it suggests the existence of a distinct mode of EC coupling in developing muscle.INTRODUCTION
The voltage-gated Ca2þ channel CaV1.1 functions as
a voltage sensor in skeletal muscle excitation-contraction
(EC) coupling. It is located in triad junctions in close appo-
sition to the Ca2þ release channel (type 1 ryanodine receptor
(RyR1)) in the sarcoplasmic reticulum (SR). On depolariza-
tion of the surface membrane, CaV1.1 undergoes a conforma-
tional change that rapidly activates the Ca2þ release channel,
presumably via protein-protein interactions. Ca2þ influx
through the voltage-gated Ca2þ channel is not required for
activation of skeletal muscle EC coupling. As a matter of
fact, L-type Ca2þ currents through CaV1.1 activate very
slowly and at more positive membrane potentials than EC
coupling (for review, see Melzer et al. (1)). Therefore, it is
unlikely that during a short skeletal muscle action potential
Ca2þ channels contribute significant amounts of Ca2þ to
the transients that trigger contraction.
Multiple splice variants greatly enrich the functional
diversity of the CACNA1 gene family and the splicing
patterns are conserved across different members of this
gene family and across various species (2). Splicing has
been extensively studied for the cardiac CaV1.2 encoded
by CACNA1C (3–8) and for the neuronal CaV2.1 (CAC-
NA1A) and CaV2.2 (CACNA1B) (9–11). In contrast, only
one CaV1.1 splice variant has so far been described in rabbit
skeletal muscle. Skipping of exon 29 (5) shortens the extra-
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0006-3495/09/01/0035/10 $2.00cellular loop connecting transmembrane domains IVS3 and
IVS4. This loop is a conserved splicing site of CaV1 a1
subunits that has been shown to generate differentially
distributed and functionally distinct channel variants. For
example, the CaV1.3 and CaV2.2 IVS3–IVS4 splice variants
are expressed in different regions of the cardiovascular
system and the nervous system, respectively (11,12), and
skipping of the corresponding exon in the smooth muscle
variant of CaV1.2 resulted in a channel with increased volt-
age and drug sensitivity (13). For the skeletal muscle
CaV1.1, the functional consequence of exon skipping in
IVS3–IVS4 or the specific expression patterns of this splice
variant have hitherto not been analyzed.
In this study, we describe CaV1.1 splice variants tran-
scribed in human adult muscle and in muscle cell cultures.
Because the variant lacking exon 29 (CaV1.1D29) was
predicted to code for a functional channel and was abun-
dantly expressed in myotubes, we performed a thorough
analysis of its biophysical properties. Reconstitution of
dysgenic (CaV1.1-null) myotubes with CaV1.1D29 fully
restored skeletal muscle EC coupling, however, with Ca2þ
currents eight times larger and activating at 30 mV less depo-
larizing potentials than CaV1.1 with exon 29. Thus, the
analysis of the CaV1.1D29 splice variant identified the
IVS3–IVS4 loop as the structural basis of the weak voltage
sensitivity of the full-length skeletal muscle Ca2þ channels.
Furthermore, our results indicate that in muscle cells express-
ing this newly characterized channel variant, Ca2þ influx
contributes significantly to the cytoplasmic Ca2þ signal
that triggers skeletal muscle contraction.
doi: 10.1016/j.bpj.2008.09.027
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Detection of splice variants
Muscle biopsies (Vastus lateralis of five control subjects with their in-
formed consent) were shredded and trypsinized for 30 min at 37C. Satel-
lite cells were isolated by filtration (nylon filter, 0.22 mm) and cultured in
skeletal muscle growth medium (PromoCell, Heidelberg, Germany). After
10–14 days, the medium was changed to a differentiation medium (Promo-
Cell). Mature myotubes (those with more than five nuclei) were obtained
after an additional 1–2 weeks. Total RNA was extracted from homogenized
mouse muscle tissues and cultured myotubes using TRIzol reagent (Gibco
BRL, Gaithersburg, MD) according to the manufacturer’s protocol. Re-
verse transcription polymerase chain reaction (RT-PCR) amplification
was carried out with a one-step RT-PCR kit (Qiagen, Hilden, Germany)
and overlapping primer pairs (see Table S3 in Supplementary Material).
DNA fragments of splice variants were separated by 2% agarose gel elec-
trophoresis and stained with ethidium bromide (0.7 mg/ml). Size and inten-
sity of PCR bands were quantified using Scion Image 4.0.3.2 (Scion,
Frederick, MD). DNA sequences of splice variants were confirmed
sequencing (BIG Dye Terminator Cycle Sequencing Kits, Applied Biosys-
tems, Foster City, CA).
Quantitative TaqMan PCR
Total RNAwas isolated from differentiated myotubes from a skeletal muscle
cell line derived from H2-KB-TSA58 mice (Immortomice (14,15)) using
the RNeasy Mini kit (Qiagen) and reverse-transcribed (SuperScriptII, Invi-
trogen, Carlsbad, CA). The relative abundance of CaV1.1 and CaV1.1D29
mRNAs was assessed by TaqMan quantitative PCR (50 cycles) using a stan-
dard curve method based on PCR products of known concentrations (16).
TaqMan gene expression assays, designed to span exon-exon boundaries
(Table S3), were purchased from Applied Biosystems. cDNA concentrations
of the three individual experiments were comparable, as revealed by the
expression of seven different reference genes (b-actin, B2M, GAPDH,
HPRT1, Tbp, Tfrc, and SDHA). Analyses were performed using the
7500 Fast System (Applied Biosystems).
Expression plasmids
Bases 3609–3666, corresponding to exon 29, were deleted from GFP-a1S
(17) by PCR splicing using a primer pair encompassing restriction sites
upstream (XhoI) and downstream (BglII) of exon 29 (P1 and P2 (Table
S3)), and two complementary primers each consisting of the end sequence
of exon 28 joined to the start sequence of exon 30 (P3 and P4 (Table
S3)). a2d-1 shRNA expression plasmid has been previously published (18).
Cell culture and transfections
Myotubes of the homozygous dysgenic (mdg/mdg) cell line GLT were
cultured and transfected as previously described (19). Myotubes were
analyzed 3–5 days after transfection.
Immunoﬂuorescence and antibodies
Immunofluorescence analysis was performed as described (20), using the
following antibodies: rabbit polyclonal anti-GFP (1:4000, Molecular Probes,
Eugene, OR); mouse monoclonal anti-RyR (34-C, 1:1000, Alexis Bioche-
memicals, Lausen, Switzerland); secondary goat-anti-mouse Alexa-594
and goat-anti-rabbit Alexa-488 (1:4000, Molecular Probes). Images were
captured on a Zeiss Axiophot microscope with a cooled CCD camera
and METAVUE image-processing software (Universal Imaging, West
Chester, PA).
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Ca2þ currents were recorded with the ruptured whole-cell patch-clamp tech-
nique in voltage-clamp mode. The patch pipettes (borosilicate glass, Harvard
Apparatus, Holliston, MA) had resistance of 1.5–3 MU when filled with
(mM) 145 Cs-aspartate, 2 MgCl2, 10 HEPES, 0.1 Cs-EGTA, 2 Mg-ATP,
and 0.2 Fluo-4, with pentapotassium salt to record Ca2þ transients (pH
7.4 with CsOH). The extracellular bath solution contained (mM)
10 CaCl2, 145 tetraethylammoniumchloride, 10 HEPES (pH 7.4 with
tetra-ethylammoniumhydroxide). Recording of gating charge movement
was performed in the presence of 0.5 mM Cd2þ and 0.2 mM La3þ (Cd2þ/
La3þ) to block the inward Ca2þ currents. All recordings were made with
an Axopatch 200A amplifier (Axon Instruments, Foster City, CA). Data ac-
quisition and command potentials were controlled by pClamp software (ver-
sion 8.0, Axon Instruments).
The current-voltage dependence was fitted according to
I ¼ Gmax  ðV  VrevÞ=

1 þ exp V  V1=2

=k

; (1)
where Gmax is the maximum conductance of the L-type Ca
2þ channels, Vrev
is the extrapolated reversal potential of the Ca2þ current, V1/2 is the potential
for half-maximal conductance, and k is the slope.
The voltage dependence of the Ca2þ conductance, ‘‘On’’ gating charge
movement, and Ca2þ transients were fitted according to a Boltzmann
distribution:
G ¼ Gmax=

1 þ exp V  V1=2

=k

: (2)
The kinetic properties of the Ca2þ current activation were determined by
fitting the rising phase of the maximum sweep (þ40 orþ50 mV for GFP-a1S
and þ10 or þ20 mV for GFP-a1SD29 and GFP-a1SD29 þ a2d-1 siRNA)
with a single- or double-exponential function:
I ¼ Afast 

exp
t=tfast
 þ Aslow  ðexpðt=tslowÞÞ þ C or
I ¼ Amono  ðexpðt=tmonoÞÞ þ C; (3)
where I is the current; Afast, Aslow, and Amono are the individual current
amplitudes; and tfast, tslow, and tmono are the specific time constants of the
current amplitudes.
RESULTS
Human and mouse skeletal muscles express
transcripts of multiple CaV1.1 splice variants
To determine the genetic variability of the skeletal muscle
voltage-gated Ca2þ channel, we performed an RT-PCR
screen for CaV1.1 splice variants on RNA from human and
mouse muscle and cultured myotubes. We identified nine
rare variants coding for nonsense proteins, each of which
made up <3% of transcripts in myotubes and muscle (Table
S1 and Fig. S1). Eight of these produced frame shifts result-
ing in premature stops, precluding formation of functional
channels. The ninth, a deletion of exon 19, lacks almost an
entire transmembrane segment and would thus invert the
transmembrane orientation of the channel distal to IIIS1.
Most likely, all of these transcripts are subject to nonsense-
mediated decay, a process that affects transcripts with prema-
ture termination codons (21).
Further, we identified three C-terminal CaV1.1 variants, all
of which code for truncated but putatively functional
proteins (Table S2). Deletion of exons 39–40 results in
New Skeletal Muscle Ca2þ Channel Variant 37a premature stop after only three residues. Alternative 50
splicing of exon 40 results in the in-frame deletion of 26 res-
idues in positions 1599–1625. The insertion of intron 43 gen-
erates a protein with 61 residues at the C-terminus. Because
the distal end of the channel has previously been shown to
exert an autoinhibitory effect on gating charge movements
and Ca2þ currents (22), all three C-terminal variants are
expected to result in a gain of function similar to an artificial
truncation at position 1698. Transcripts of all three C-termi-
nal variants were expressed in low abundance.
Finally, the RT-PCR screen revealed an in-frame deletion
of exon 29 (D29) (Fig. 1 A) that encodes a 1854-amino-acid
protein lacking 19 residues in the extracellular loop between
transmembrane segments IVS3 and IVS4 (Fig. 1 B). This
CaV1.1 variant had previously been identified in mouse ova-
ries, in the BC3H1 cell line (5), and in rat osteosarcoma cells
(23). Quantifying the RT-PCR bands of the full-length and
splice-variant Ca2þ channels showed that CaV1.1D29 was
expressed at low levels in differentiated muscles from man
and mouse (2–10% of transcripts), but was abundant in pri-
mary human myotubes and in the C2C12 mouse muscle cell
line (60–80% of transcripts (Fig. 1 C)). Taqman RT-PCR,
using assays spanning the borders between exons 28–29
and exons 28–30 (Table S3), confirmed the high expression
levels of CaV1.1D29 in an additional skeletal muscle cell
line. Of the CaV1 transcripts in RNA from myotubes derived
from the Immortomouse, 775 3% lacked exon 29 (Fig. 1D).
Together, these data show that CaV1.1D29 is the pre-
dominant CaV1.1 isoform in skeletal myotubes. Analogous
splice variants in other L-type Ca2þ channel a1 subunits
code for functional channels. Thus, it is likely also that
CaV1.1D29 is functional and thus may be of physiological
relevance.
CaV1.1D29 is localized in the EC-coupling
apparatus
To analyze the physiological properties of CaV1.1D29, we
deleted the sequence corresponding to amino acids 1203–
1222 in the GFP-tagged CaV1.1 a1S subunit (17) and
expressed the resulting construct, GFP-a1SD29, in dysgenic
(a1S-null) myotubes. Reconstitution of dysgenic myotubes
with GFP-a1S restores normal triad targeting of the GFP-a1S
subunit (Fig. 2, left column) as well as skeletal muscle
EC coupling (20). Double-immunofluorescence analysis of
GFP-a1SD29-transfected myotubes showed that, like the
wild-type GFP-a1S, GFP-a1SD29 was localized in a clustered
pattern that was colocalized with clusters of RyR1 (Fig. 2,
right column). This labeling pattern is typical for triad
proteins and indicates that GFP-a1SD29 is correctly targeted
into junctions between the SR and t-tubules or the plasma
membrane, and thus can function in EC coupling (20).
CaV1.1D29 has distinct current properties
Whole-cell patch-clamp recordings in dysgenic myotubes
reconstituted with GFP-a1SD29 revealed greatly aug-
mented Ca2þ currents (Fig. 3 A). Mean peak current den-
sity was increased eightfold from 1.9 5 0.2 pA/pF in
FIGURE 1 Detection of GFP-a1SD29 in human and mouse myotubes. (A) Sequence of the boundary between exons 28 and 30. (B) Location of exon 29 in
a domain model of CaV1.1. (C) Full-length (upper band) and CaV1.1D29 (lower band) detected by RT-PCR amplification of exons 26–30 in RNA prepared
from mouse muscle, C2C12 myotubes, human muscle, and human primary myotubes. (D) The fraction of CaV1.1 transcripts with and without exon 29 mea-
sured with quantitative RT-PCR in mRNA from mouse myotubes. Error bars represent the mean5 SE, p << 0.001.
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38 Tuluc et al.GFP-a1S-expressing myotubes to 14.85 1.2 pA/pF in myo-
tubes expressing GFP-a1SD29 (Fig. 3 B and Table 1). More-
over, the current-voltage curves showed a greatly increased
voltage sensitivity. The half-maximal activation was shifted
from 39.15 1.3 mV for the wild-type to 9.35 1.0 mV for
the GFP-a1SD29 channel (Fig. 3 C). Because at less
positive voltages the driving force for Ca2þ currents is larger,
the left-shifted voltage dependence of activation accounted in
part for the observed increase in current density.
To determine whether enhanced membrane expression of
Ca2þ channels also contributed to the increase in current
density, we analyzed the charge movements upon channel
activation in the presence of Cd2þ/La3þ to block the Ca2þ
conductance (Fig. 3 D). The integral of the immobiliza-
tion-resistant ‘‘On’’ gating charge movement (Qon) is a mea-
sure of functional Ca2þ channels in the membrane (24). In
myotubes expressing GFP-a1S or GFP-a1SD29, Qon was
not significantly different at any voltage (Fig. 3 E), indicating
that membrane expression of functional Ca2þ channels was
not changed in the variant lacking exon 29. Alternatively, al-
tered single-channel conductance could be responsible for
the increased current density. Therefore, we analyzed the
tail currents at the end of 200-ms test pulses to near the rever-
sal potential, where a maximal number of channels should be
activated (Fig. 3 F), and we plotted the peak current density
of the tail currents against the integral of Qon (25). The slope
of the linear regression was increased from 0.38 5 0.07
(GFP-a1S) to 3.59 5 0.89 (GFP-a1SD29) (Fig. 3 G). This
indicated that deletion of exon 29 caused a significant
increase in the relative open probability (Po) (Table 1).
Together, electrophysiological analyses demonstrated that
compared to the full-length isoform, the CaV1.1D29 splice
variant has a greatly increased voltage sensitivity and open
probability, resulting in an eightfold increase of the whole-
cell Ca2þ currents.
CaV1.1D29 has accelerated current kinetics
Another property of the Ca2þ current that was altered by the
deletion of exon 29 was the speed of activation and inactiva-
tion. This is evident in the representative current traces
shown in Fig. 3 A. The average time to peak measured in
the maximum current traces was significantly reduced from
84.7 5 6.3 ms (GFP-a1S) to 39.8 5 4.5 ms (GFP-
a1SD29) (Fig. 4 A). In a similar way, the fractional inactiva-
tion at the end of the 200-ms test pulse increased from 4.75
1.2% to 23.825 2.0% (Fig. 4 B).
Toelucidate themechanismofCa2þ-current accelerationwe
further analyzed the activation phase by fitting the maximum
current traces. Kinetic analysis of GFP-a1SD29-expressing
FIGURE 2 GFP-a1SD29 is targeted into junctions between the SR and t-tubules or the plasma membrane. Dysgenic myotubes expressing full-length
GFP-a1S (left) or the GFP-a1SD29 splice variant (right) were double-immunolabeled with anti-RyR (upper) and anti-GFP (middle). Clusters of GFP-a1S
and GFP-a1SD29 colocalized with the RyR1 (lower, yellow clusters in color overlay) indicate the correct targeting of both Ca
2þ channel variants into
t-tubule/SR or plasma membrane/SR junctions. Scale bar, 10 mm.
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New Skeletal Muscle Ca2þ Channel Variant 39FIGURE 3 GFP-a1SD29 has increased current density, voltage sensitivity of activation, and open probability (Po). (A) Representative whole-cell currents
from myotubes expressing either GFP-a1S or GFP-a1SD29. (B) I/V curves show that the peak current density of GFP-a1SD29 is increased. (C) Voltage de-
pendence of activation is shifted toward more negative potentials for GFP-a1SD29 compared to full-length GFP-a1S. (D and E) Analysis of the ‘‘On’’ gating
charges (Qon) while currents are blocked with Cd
2þ/ La3þ shows that deletion of exon 29 did not alter the expression of functional channels in the membrane.
(F and G) The amplitudes of the tail currents, recorded at the reversal potential were plotted against Qon. The increased slope of the linear regression indicates
that the channel Po is considerably increased in GFP-a1SD29 compared to GFP-a1S. Error bars indicate the SE.myotubes using a double-exponential function (26) showed
that the majority of the currents consisted of a fast- and
a slow-activating component. Whereas the relative abun-
dance of both components (Fig. 4 C), and the time constant
of the fast component, were equal for GFP-a1S and
GFP-a1SD29, the time constant of the slow component was
significantly faster (14.1 5 2.5 ms) compared to that of
GFP-a1S (28.7 5 3.3 ms) (n ¼ 18) (Fig. 4 D and Table 1).
In addition, activation kinetics of 15 out of 33 currents were
best described by a single-exponential function with a time
constant equal to that of tfast in the currents with two activa-
tion components (Table 1). Whether this resulted from an
even greater acceleration of the slow component or from
an almost complete loss of its contribution to the whole-
cell current cannot be discerned.
CaV1.1D29 interacts with the a2d-1 subunit
Previously, we reported that depletion of the Ca2þ channel
a2d-1 subunit with siRNA also accelerated Ca
2þ current ki-
netics (18). Therefore, we examined whether GFP-a1SD29
currents were affected by depletion of a2d-1. Fig. 5 A shows
that coexpressing dysgenic myotubes with GFP-a1SD29 and
a plasmid coding for a2d-1 shRNA further accelerated
activation and inactivation of Ca2þ currents compared to
those expressing GFP-a1SD29 alone. Knock-down of a2d-1showed a 42% decrease in time to peak to 22.9 5 0.1 ms
(Fig. 5 B and Table 2), and a 22% increase in the fractional
inactivation to 30.65 0.2% (Fig. 5 C). Moreover, as previ-
ously shown for GFP-a1S, it is also the case with
GFP-a1SD29 that the rising phase of all currents in a2d-1-
depleted myotubes was best fitted by a single-exponential
function (Fig. 5 D). This indicates that GFP-a1SD29 still
interacted with the a2d-1 subunit in skeletal myotubes. Fur-
thermore, immunocytochemical analysis demonstrated that
the deletion of exon 29 did not affect triad targeting of the
a2d-1 subunit (Fig. S2). Thus, the mechanisms by which
the IVS3–IVS4 loop and the a2d-1 subunit regulate activa-
tion kinetics are independent of each other.
CaV1.1D29 supports skeletal muscle EC coupling
with a substantial component of Ca2þ inﬂux
CaV1.1 Ca
2þ currents activate slowly and at much higher
membrane potentials than depolarization-induced Ca2þ re-
lease from the SR. As a consequence, Ca2þ influx through
the CaV1.1 Ca
2þ channel does not essentially contribute to
skeletal muscle EC coupling (1). However, the current prop-
erties of GFP-a1SD29 described above resemble much more
those of the cardiac CaV1.2, which activates EC coupling by
Ca2þ-induced Ca2þ release (27). Therefore, it was important
to determine whether GFP-a1SD29 can trigger EC coupling
Biophysical Journal 96(1) 35–44
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Parameters a1S a1S-DE29 Significance (p-value)
Current properties Ipeak (pA/pF) 1.95 0.2 14.85 1.2 <<0.001
Gmax (nS/nF) 79.15 8.4 255.15 17.8 <<0.001
V1/2 (mv) 39.15 1.3 9.35 1.0 <<0.001
kact (mv) 7.25 0.4 4.85 0.3 <<0.001
Vrev (mv) 82.75 2.1 83.15 0.8 0.81
n 26 33 —
Kinetics Time to peak (ms) 84.75 6.3 39.85 4.5 <<0.001
% Inactivation 4.75 1.2 23.85 2.0 <<0.001
n 26 33 —
Aslow contribution 62% 65% 0.24
Afast contribution 38% 35% 0.24
Aslow (pA/pF) 1.45 0.3 7.95 1.3 <<0.001
Afast (pA/pF) 0.95 0.1 3.95 0.9 0.001
tslow (ms) 28.75 3.3 14.15 2.5 0.003
tfast (ms) 5 5 0.5 3.95 0.6 0.15
n 21 18 —
Amono (pA/pF) — 20.15 3.2 —
tmono (ms) — 4.35 0.2 —
n — 15 —
Charge movement QON(nC/mF) 4.15 0.9 3.95 0.5 0.90
Slope 19.85 2.2 15.55 0.9 0.07
V1/2 (mv) 14.35 5.6 7.85 2.6 0.28
n 8 10 —
QON vs. ITail ITail (pA/pF) 5.75 0.8 40.35 7.3 <0.001
Slope 0.385 0.07 3.595 0.89 —
n 10 12
All data are presented as mean5 SE.in skeletal myotubes, and if so, by which mechanism. To this
end, we measured Ca2þ transients during patch-clamp exper-
iments using the fluorescent Ca2þ indicator Fluo-4. Fig. 6 A
shows that during a depolarizing pulse, GFP-a1SD29-ex-
pressing myotubes give rise to Ca2þ transients, indicating
that GFP-a1SD29 can activate EC coupling. Because of its in-
dependence of Ca2þ influx, skeletal muscle EC coupling
remains fully activated at test pulses to near the reversal
potential. Therefore, in myotubes expressing GFP-a1S, the
voltage-dependence curve of Ca2þ transients has the charac-
teristic sigmoidal shape (Fig. 6 B, squares). The voltage-
dependence curve of transients in GFP-a1SD29 expressing
myotubes peaks earlier and at a higher level than that of
GFP-a1S before it declines to the same level as that of
GFP-a1S (Fig. 6 B (gray stars) and Table 3). The fact that at
the reversal potential GFP-a1SD29 still activates solid Ca
2þ
transients demonstrates that it supports the skeletal muscle
ECcouplingmechanism.The early-activating additional com-
ponent is likely caused by Ca2þ entering the myotubes from
the outside through the CaV1.1D29 channel. Indeed, blocking
Ca2þ currents with Cd2þ/La3þ abolished the early peak of the
voltage-dependence curve so that it exactlymatched that of the
full-length GFP-a1S isoform (Fig. 6 B, open stars).
DISCUSSION
Here, we report the first functional characterization of a splice
variant of the skeletal muscle voltage-gated Ca2þ channel,
Biophysical Journal 96(1) 35–44and the extent to which the channel properties of
CaV1.1D29 differ from those of the classical full-length
CaV1.1 is amazing. CaV1.1D29 is normally targeted into
the triads and supports skeletal muscle type EC coupling,
but the lack of exon 29 causes drastically increased voltage
sensitivity and open probability of the channel. Alternative
splicing of the extracellular loop between transmembrane
segments 3 and 4 in the fourth homologous repeat has also
been described in other L-type and non-L-type Ca2þ chan-
nels (5,7,9–11,13,23). It is interesting to note that in all these
cases, changes in the length of the IVS3–IVS4 linker were
accompanied by changes in the voltage dependence of acti-
vation. In CaV1.2, 12 possible splicing combinations exist in
this domain, four of which have been functionally character-
ized. The IVS3–IVS4 loop of variant A was shortened by 13
amino acids and the potential of half-maximal activation (V1/2)
was left-shifted by 9.5 mV; that of variant B was 6 res-
idues shorter, with V1/2 shifted by 4.9 mV; and that of var-
iant C was 11 residues shorter, with V1/2 shifted by6.8 mV.
In variant D, a 12-amino-acid sequence was exchanged with-
out changing the total length of the IVS3–IVS4 loop, and the
voltage sensitivity remained unaltered (7). Here, we demon-
strate that the lack of exon 29 in CaV1.1D29, which shortens
the IVS3–IVS4 loop by 19 amino acids, leads to a29.8 mV
shift of the voltage dependence of activation. Together, these
observations suggest an inverse correlation of the length of
the IVS3–IVS4 loop and the voltage sensitivity of Ca2þ-
channel splice variants. From a mechanistic perspective, it
New Skeletal Muscle Ca2þ Channel Variant 41is conceivable that a shorter IVS3–IVS4 loop pulls the
positively charged voltage sensor IVS4 toward the extracellu-
lar side of the membrane and thus facilitates its transition into
the activated state upon depolarization. This would result in
an increased voltage sensitivity and an increased dwell time
in the open state.
FIGURE 4 Deletion of exon 29 accelerates Ca2þ current kinetics. (A and
B) Currents recorded from myotubes expressing GFP-a1SD29 exhibit a sig-
nificantly shorter time to peak (A) and an increased fractional inactivation
during a 200-ms pulse (B). The rising phase of Ca2þ currents was fitted
by a double-exponential function and the amplitudes and time constants
of the two components were calculated. Neither the ratio between fast and
slow components (C) nor the time constant of the fast component (D, solid
bars) was affected by the deletion of exon 29. The time constant of the slow
component was significantly faster in GFP-a1SD29 compared to GFP-a1S
(D, hatched bars). Error bars represent the mean5 SE.The distinguishing characteristics of the skeletal muscle
Ca2þ current are its extremely slow activation kinetics and
activation at very positive potentials. Using skeletal/cardiac
muscle CaV1 chimeras, a sequence including transmembrane
domain S3 and the S3–S4 loop of the first repeat was shown
to determine the slow gating mode (28). The results of this
study demonstrate the importance of a separate domain,
the IVS3–IVS4 loop, for the characteristic voltage depen-
dence of activation of CaV1.1. Indeed, Nakai et al. (28)
reported that in their chimeras, the slow and fast kinetics
did not correlate with low and high voltage sensitivity,
respectively. Our study provides independent evidence that
voltage sensitivity and activation kinetics are determined
by separate mechanisms. We have shown previously that
the auxiliary a2d-1 subunit is an important determinant of
the slow activation of CaV1.1, and that shRNA depletion
of a2d-1 accelerated current activation by increasing the pop-
ulation of fast-activating channels at the expense of slow-
activating channels (18). The voltage sensitivity of activation
was not altered by a2d-1 siRNA treatment. Although the
removal of exon 29 also accelerated activation kinetics,
this resulted from a reduced time constant of the slow-acti-
vating component. Moreover, CaV1.1D29 channels were still
sensitive to depletion of a2d-1, which caused an additional
increase in activation kinetics. Thus, two separate sequences
in the corresponding domains of the first and fourth repeats
of CaV1.1 are responsible for the characteristic kinetics and
voltage dependence of activation, respectively. Whereas
IS3 and the IS3–IS4 loop appear to cooperate with the
a2d-1 subunit in determining the activation kinetics, the
length of the IVS3–IVS4 loop determines the voltage sensi-
tivity of CaV1.1.
It is interesting that the deletion of exon 29 only affected
the voltage sensitivity of the Ca2þ current, but not that of the
‘‘On’’ gating charges and Ca2þ transients, which activate at
similarly low potentials in CaV1.1 and CaV1.1D29. Thus, the
long IVS3–IVS4 loop, and with it the voltage sensor of re-
peat 4, is rate-limiting for activation of the Ca2þ currentFIGURE 5 Deletion of exon 29 does not affect the interaction of a1 with the a2d-1 subunit. The a2d-1 subunit was depleted with shRNA in myotubes ex-
pressing GFP-a1SD29. This resulted in a further acceleration of activation and inactivation kinetics as seen in the sample recordings (A). The time to peak was
further reduced (B), and the percentage of inactivation was increased (C). Kinetic analysis of the activation phase revealed only one component of activation
(D, white bar) with a time constant equal to tfast in GFP-a1SD29 controls (E, gray bars), indicating the loss of the slow-activating component. Error bars
represent the mean5 SE.
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Parameters a1S-DE29 a1S-DE29 þ a2d-1 siRNA Significance (p-value)
Current properties Ipeak (pA/pF) 14.85 1.2 14.35 2.1 0.84
Gmax (nS/nF) 255.15 17.8 249.55 28.8 0.89
V1/2 (mv) 9.35 1.0 8.95 1.3 0.88
kact (mv) 4.85 0.3 4.55 0.3 0.70
Vrev (mv) 83.15 0.8 79.75 1.7 0.05
n 33 6 —
Kinetics Time to peak (ms) 39.85 4.5 22.875 2.1 0.12
% Inactivation 23.85 2.0 30.65 2.0 0.17
n 33 6 —
Aslow contribution 65% 0% —
Afast contribution 35% 100% —
Aslow (pA/pF) 7.95 1.3 — —
Afast (pA/pF) 3.95 0.9 — —
tslow (ms) 14.15 2.5 — —
tfast (ms) 3.95 0.6 — —
n 18 6
Amono (pA/pF) 20.15 3.2 14.15 2.38 0.28
tmono (ms) 4.35 0.2 5.35 0.42 0.07
n 15 6 —
All data are presented as mean5 SE.but not for activation of SR Ca2þ release. Removing exon
29 was sufficient to render the voltage sensor in the fourth
repeat as sensitive to depolarization as those responsible
for EC coupling. Based on elegant electrophysiological
experiments in frog muscle fibers, Feldmeyer et al. (29) (re-
viewed in Melzer et al. (1)) proposed a model according to
which CaV1.1 possesses three fast- and one slow-activating
voltage sensors, which are responsible for the activation of
EC coupling and Ca2þ currents, respectively. A similar
model would readily explain the differential voltage sensitiv-
ity of EC coupling and the Ca2þ currents. If the rapid gating
of two or three voltage sensors is sufficient for activating SR
Ca2þ release, but the gating of all four voltage sensors is
necessary for activation of the Ca2þ current, a single less re-
sponsive voltage sensor would be enough to delay current
activation. However, since the voltage sensors of repeats I
and IV appear to be involved in controlling the kinetics
and voltage sensitivity of the current, respectively, the two
other voltage sensors, those of repeats II and III, which flank
the cytoplasmic loop that interacts with the RyR1, may be
sufficient for the rapid activation of EC coupling. If, how-
ever, the short IVS3–IVS4 loop would hold the voltage
sensor of repeat IV in a constitutively activated position,
a reduction of Qon by one-fourth would have been expected
in CaV1.1D29. This was not observed. Therefore, the shorter
IVS3–IVS4 loop appears to enhance the coupling between
the voltage-dependent step and the final voltage-independent
step of channel gating.
We further demonstrate that transcripts of the CaV1.1
splice variant lacking exon 29 (CaV1.1D29) are expressed
in human and mouse muscles and that CaV1.1D29 is the
predominant isoform in human and mouse cultured myo-
tubes. If this is so, Ca2þ currents in normal myotubes like
the C2C12 cell line, which express a mix of CaV1.1 and
CaV1.1D29, should have an intermediate voltage sensitivity
compared to dysgenic myotubes expressing either GFP-a1S
FIGURE 6 GFP-a1SD29 supports skeletal muscle type
EC coupling with an additional component of Ca2þ influx.
Depolarization-induced Ca2þ transients were recorded in
dysgenic myotubes reconstituted with GFP-a1S (A, upper)
or GFP-a1SD29 (A, lower). The voltage dependence of ac-
tivation was not altered by the deletion of exon 29, but
Ca2þ transients were augmented by a component that de-
clined at voltages near the reversal potential and could be
inhibited by blocking Ca2þ currents with Cd2þ/La3þ (B).
Error bars represent the mean5 SE.
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Parameters a1S-WT a1S-DE29 Significance (p-value)
Transients before Cd2þ/La3þ DF/F 0.635 0.07 0.815 0.10 0.44
V1/2 (mv) 4.85 1.1 1.05 1.0 0.02
kact (mv) 7.15 0.16 6.25 0.25 0.005
n 15 16 —
Transients after Cd2þ/La3þ DF/F 0.6450.06 0.555 0.08 0.33
V1/2 (mv) 6.85 1.4 8.15 1.7 0.55
kact (mv) 8.45 0.3 9.45 0.9 0.27
n 15 13 —
All data are presented as mean5 SE.or GFP-a1SD29. Indeed, this was observed in two previous
studies by Schuhmeier et al. (30,31), who determined the
voltage sensitivity of Ca2þ currents and Ca2þ transients in
reconstituted dysgenic myotubes and in C2C12 myotubes.
Consistent with the data presented here, in dysgenic myo-
tubes transfected with GFP-a1S, half-maximal activation of
Ca2þ currents occurred at ~30 mV higher potentials than
activation of Ca2þ transients. In contrast, this difference
was only ~15 mV in C2C12 cells. Thus, the current properties
of cultured myotubes most likely reflect the properties of
a mixed population of CaV1.1 splice variants.
Finally, CaV1.1D29 was correctly incorporated into triad
junctions and supported skeletal muscle type EC coupling,
although the highly increased voltage sensitivity and ampli-
tude of Ca2þ currents altered the EC coupling properties.
Dysgenic myotubes exclusively expressing the GFP-
a1SD29 isoform showed depolarization-dependent Ca
2þ
transients, which did not require Ca2þ influx through the
channel. In addition, the rapidly activating Ca2þ current con-
tributed significant amounts of Ca2þ to the cytoplasmic Ca2þ
transients. Under physiological conditions, this component
will be diminished by the presence of the full-length
CaV1.1. Nevertheless, the additional Ca
2þ influx is expected
to increase the force of contraction and it creates the need for
increased export of Ca2þ from the cell to maintain equilib-
rium. The observation that CaV1.1D29 transcripts were
highly expressed in cultured myotubes from humans and
mice suggests a physiological role of this splice variant in
developing and regenerating muscle. It is plausible that
myotubes with an incompletely differentiated SR Ca2þ stor-
age and release apparatus require more Ca2þ influx and rely
part on a cardiac-like EC coupling mechanism. Moreover,
given the great variety of muscle types in our body it is
intriguing to consider the possibility that CaV1.1D29 may
also play a role in some type of differentiated muscle.
Finally, CaV1.1 mutants affecting Ca
2þ current properties
have been linked to human disease, but the effects of these
disease mutants on EC coupling were small (32,33). In light
of the existence of a splice variant with dramatically different
current properties and its possible function during develop-
ment, the effects of these disease mutations on this splice
variant, as well as the possible pathological consequences,
need to be investigated.SUPPLEMENTARY MATERIAL
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